These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 26610922
1. Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity. Li IH, Ma KH, Kao TJ, Lin YY, Weng SJ, Yen TY, Chen LC, Huang YS. Neurotoxicology; 2016 Jan; 52():114-26. PubMed ID: 26610922 [Abstract] [Full Text] [Related]
2. Autophagy activation is involved in 3,4-methylenedioxymethamphetamine ('ecstasy')--induced neurotoxicity in cultured cortical neurons. Li IH, Ma KH, Weng SJ, Huang SS, Liang CM, Huang YS. PLoS One; 2014 Jan; 9(12):e116565. PubMed ID: 25551657 [Abstract] [Full Text] [Related]
3. Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats. Shih JH, Chiu CH, Ma KH, Huang YS, Shiue CY, Yeh TY, Kao LT, Lin YY, Li IH. Pharmacol Res; 2019 Apr; 142():283-293. PubMed ID: 30826457 [Abstract] [Full Text] [Related]
4. MDMA-induced neurotoxicity of serotonin neurons involves autophagy and rilmenidine is protective against its pathobiology. Mercer LD, Higgins GC, Lau CL, Lawrence AJ, Beart PM. Neurochem Int; 2017 May; 105():80-90. PubMed ID: 28122248 [Abstract] [Full Text] [Related]
5. Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study. Shih JH, Ma KH, Chen CF, Cheng CY, Pao LH, Weng SJ, Huang YS, Shiue CY, Yeh MK, Li IH. Eur Neuropsychopharmacol; 2016 Jan; 26(1):92-104. PubMed ID: 26612383 [Abstract] [Full Text] [Related]
6. Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET. Li IH, Huang WS, Shiue CY, Huang YY, Liu RS, Chyueh SC, Hu SH, Liao MH, Shen LH, Liu JC, Ma KH. Neuroimage; 2010 Jan 15; 49(2):1259-70. PubMed ID: 19682588 [Abstract] [Full Text] [Related]
7. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. Biezonski DK, Meyer JS. J Neurochem; 2010 Feb 15; 112(4):951-62. PubMed ID: 20002520 [Abstract] [Full Text] [Related]
8. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A. J Psychopharmacol; 2006 Mar 15; 20(2):211-25. PubMed ID: 16510479 [Abstract] [Full Text] [Related]
9. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users. Erritzoe D, Frokjaer VG, Holst KK, Christoffersen M, Johansen SS, Svarer C, Madsen J, Rasmussen PM, Ramsøy T, Jernigan TL, Knudsen GM. Arch Gen Psychiatry; 2011 Jun 15; 68(6):562-76. PubMed ID: 21646575 [Abstract] [Full Text] [Related]
10. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies. Vegting Y, Reneman L, Booij J. Psychopharmacology (Berl); 2016 Oct 15; 233(19-20):3473-501. PubMed ID: 27568200 [Abstract] [Full Text] [Related]
11. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine. Lizarraga LE, Cholanians AB, Phan AV, Herndon JM, Lau SS, Monks TJ. Toxicol Sci; 2015 Jan 15; 143(1):209-19. PubMed ID: 25370842 [Abstract] [Full Text] [Related]
12. Low ambient temperature reveals distinct mechanisms for MDMA-induced serotonergic toxicity and astroglial Hsp27 heat shock response in rat brain. Adori C, Andó RD, Balázsa T, Soti C, Vas S, Palkovits M, Kovács GG, Bagdy G. Neurochem Int; 2011 Oct 15; 59(5):695-705. PubMed ID: 21756954 [Abstract] [Full Text] [Related]
14. Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage. Costa G, Morelli M, Simola N. Neurotox Res; 2017 Nov 15; 32(4):563-574. PubMed ID: 28597409 [Abstract] [Full Text] [Related]
15. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan. Wang X, Baumann MH, Dersch CM, Rothman RB. Neuroscience; 2007 Aug 10; 148(1):212-20. PubMed ID: 17629409 [Abstract] [Full Text] [Related]
16. Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells. Popova D, Forsblad A, Hashemian S, Jacobsson SO. PLoS One; 2016 Aug 10; 11(11):e0166750. PubMed ID: 27861613 [Abstract] [Full Text] [Related]
17. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain. Kirilly E. Neuropsychopharmacol Hung; 2010 Sep 10; 12(3):413-23. PubMed ID: 20962361 [Abstract] [Full Text] [Related]
18. Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[18F]-ADAM PET Imaging. Tsai CJ, Chiu CH, Kuo YY, Huang WS, Yu TH, Flores LG, Yeh SH, Ma KH. Int J Mol Sci; 2022 Jun 24; 23(13):. PubMed ID: 35806049 [Abstract] [Full Text] [Related]
19. A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons. Orio L, Llopis N, Torres E, Izco M, O'Shea E, Colado MI. Neurotox Res; 2010 Aug 24; 18(2):187-99. PubMed ID: 19777321 [Abstract] [Full Text] [Related]
20. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain. Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM, Green AR. Br J Pharmacol; 2001 Dec 24; 134(8):1711-23. PubMed ID: 11739248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]